Table 3.
Levels of concurrent risk factors in patients receiving COX-2 inhibitors.
Cumulative number of risk factors or drug interactions identified in patients | Number of patients with concurrent risk factors (%) | Number of patients with concurrent drug interactions (%) |
---|---|---|
0 | 219 (34.9%) | 298 (47.5%) |
1 | 191 (30.5%) | 201 (32.1%) |
2 | 154 (24.6%) | 90 (14.4%) |
3 | 47 (7.5%) | 38 (6.1%) |
4 | 14 (2.2%) | 0 |
5 | 2 (0.3%) | 0 |